Barclays raised the firm’s price target on Universal Health (UHS) to $257 from $249 and keeps an Overweight rating on the shares post the Q1 report. The company delivered a solid beat despite lagging behavioral volumes impacted by weather and leap year, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS: